Skip to main content

Introduction of Cleaning validation

Introduction

        The primary benefit usually attributed to a cleaning validation  is ensuring compliance with federal regulation. However, a more important benefit from conducting cleaning validation work is the identification and correction of potential problem, previously unsuspected, which could compression the safety, efficacy, or quality of subsequent batches of the drug product produced with the equipment.

    Several serious problem can be prevented through the use of the reasonable cleaning validation program. All are related to adulteration, therapeutic safety and efficacy, or overall quality of the product over its shelf life.

Cross contamination with active ingredients:  Contamination of one batch of product with significant level of residual active ingredients from a previous batch cannot be tolerated. 

Contamination with unintended material or components: Excipients used in drug products are generally recognized as safe or have been shown to be safe for human consumption, the routine use, maintenance and cleaning of equipment provide the potential for contamination with such items as equipment parts and lubricants, chemical cleaning agents and peace of cleaning tools. Contamination from such item can cause problem ranging from poor pharmaceutical elegance, to exceeding acceptable level of particulate matter in parenteral products, to inadvertent inclusion of toxic compounds in the product.  

Microbiological contamination: Maintenance, cleaning and storage conditions may provide adventitious microorganism with the opportunity to proliferate within process equipment. This could pose obvious problem for sterile product manufacture. It can also be a serious problem for the manufacture of nonsterile dosage forms, particularly unpreserved product which support microbial growth.

The major objective of cleaning validation program should be to provide an adequate level of assurance that the problem described above will not occur during routine manufacturing operation. Cleaning validation can provide fairly high level of assurance of product safety, purity, and efficacy. 

Comments

Popular posts from this blog

Hold Time study for Pharmaceutical products

Introduction: Manufacture should ensure that the products they are manufacture are safe, effective and quality required for intended use. System should be in-place and in-use to ensure that the products manufactured as per validated process. As per Good manufacturing practices, manufacture should ensure that the dispensing raw materials and packing materials, intermediates products, bulk and finished product are stored under suitable conditions. Storage arrangement should be such which safeguard the subsequent processing, stability, safety, efficacy or quality of starting materials, intermediate products, and bulk drug prior to final packing. Maximum hold time should be established to ensure that intermediate and bulk product can be held without producing results outside the acceptance criteria for the quality of the material. Intermediate and bulk product should not be store beyond the established hold time. The choice of maximum hold time should be supported by relevant data. man...

Good Laboratory practices and Requirements of Premises and Equipment's.

Good Laboratory Practices and Requirement of premises and Equipment's General Requirements:- a) The laboratory or the the organization of which it is a part must be an entity that is legally authorized to function and can be held legally responsible. b) Management ensures that the laboratory carry out its testing, calibration, validation, and all other technical activities in such a way as to meet Good Laboratory Practices (GLP) requirements.  c) The Quality manger shall prepare a schedule for technical audit of the laboratory for GLP compliance by an expert or experts appointed by the top-management other than the in-charge of the laboratory and shall ensures the maintenance of documented quality systems as per quality manual. Premises:- a) The laboratory shall be designed, constructed and maintained so as to prevent entry of insects and rodents besides cross contamination. b) Wall, floor and ceilings ( interior surface) shall be smooth and free from cracks and permits easy cleani...

Revised schedule M 2023.

 Dear friend's Hope all of you are doing well....! Schedule M has been received and notified on 28th December 2023. There are many changes as compare to previous version. The revised schedule M is divided into thirteen parts. In coming days I will provide the summary of these changes in this site for your easy reference. This change impacts all the pharmaceutical manufacturing plants in India. See you...